Gapping up
In reaction to strong earnings/guidance: NPTN +26.6%,
SEDG +15.6%,
IMPV +11.9%,
WPRT +10.8%,
CALA +10.3%,
SSNI +9.8%,
PLPM +9.7%,
HNSN +8.3%,
DATA +7.8%,
DATA +7.8%,
STMP +7.1%,
RMTI +6.9%,
VICL +6.7%,
XOMA +6.4%,
AERI +6.1%,
OUTR +5.6%,
SAAS +5.5%,
FUEL +5.5%,
BKD +5.3%,
AOL +5%,
BITA +4%,
MOH +3.9%,
NUAN +3.5%,
GSAT +3.5%,
RLYP +3.5%,
CYBR +3.4%,
ACAD +3.3%,
RYI +3.3%,
ACET +3%,
BONA +2.9%,
RBA +2.9%,
SWIR +2.8%,
ALSK +2.7%,
CPXX +2%,
PGH +2%,
AIRM +1.9%,
TRAK +1.9%,
CUTR +1.1%,
RGLS +1.1%,
GSVC +1.1%,
CBS +1%,
TRUE +1%,
AEZS +1%,
KTOS +0.9%,
CNAT +0.7%,
JMBA +0.5%,
ESPR +0.5%,
NRG +0.5%
M&A news: SYT +11.2% (reports that co may be acquired by Monsanto (MON))
MCRL +3.7% (Micrel to be acquired by Microchip Technology (MCHP) for $14.00 per share)
Select large pharma related names showing strength: SGEN +3.8%,
AZN +3.5%,
GSK +3.1%,
SHPG +3.1%
Select oil/gas related names showing strength: RDS.A +2.6%,
BP +2.2%,
TOT +2.1%,
SDRL +1.1%,
XOM +0.7%
Other news: WLT +27.1% (confirmed last night it will make interest payments, continue discussions with debtholders),
GEVO +20.3% (cont strength),
MNGA +19% (announces that a major cement company in the U.S. has approved MagneGas fuel to replace acetylene and has placed their first order for a location in Florida),
NVGN +14.5% (move being attributed to press release regarding the presentation of positive pre-clinical date for TRXE-009 for the treatment of brain cancer),
NDRM +14.2% (announces the FDA has lifted its clinical hold on ND0612 candidates, after a review of additional information related to the product candidates' delivery devices),
ICLD +11.3% (announces that its cloud team has been engaged by a large east coast auto parts distributor and wholesaler to design, migrate and implement a cloud solution),
SCMP +6.1% (announced that the FDA has granted Fast Track Designation for Cobiprostone, for the prevention of oral mucositis), TOUR +4.9% (announces $500 mln investment from a group of investors),
AMRN +3% (discloses lawsuit against the FDA seeking a judicial declaration that an FDA regulation limiting off-label promotion is unconstitutional ),
ERIC +2.6% (asserts patents against Apple (AAPL) in Germany, the UK and the Netherlands),
NOK +1.3% (seeing reports that Uber has joined in bidding for co's maps unit; bidding up to $3 bln),
LYB +1% (announces a new share repurchase agreement for up to 10% of its shares; increases quarterly dividend to $0.78/share from $0.70/share),
BIIB +0.8% (announces Board authorization for a $5 bln share repurchase program, in addition to its existing 1.3 mln share authorization )
Analyst comments: ALU +3.8% (upgraded to Buy at UBS),
BABA +1.1% (upgraded to Buy from Neutral at Goldman),
IVR +1% (upgraded to Outperform from Mkt Perform at Keefe Bruyette),
PM +0.8% (upgraded to Neutral from Sell at Goldman)